project id: TCGA-CESC; case submitter id: TCGA-EK-A2H0; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.1; spectrophotometer method: UV Spec; age at index: 24; days to birth: -8918; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1983; age at diagnosis: 8918; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1847.0; figo stage: Stage IIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1268; initial weight: 160.0; oct embedded: false; preservation method: Unknown; sample id: cee04dec-391c-4c22-bc7d-d3dd36380db3; sample submitter id: TCGA-EK-A2H0-01A; portion id: 49eef2f2-e077-4929-9773-6cd9c5164a9b; portion submitter id: TCGA-EK-A2H0-01A-11; slide id: 1f5a10e3-2c42-4623-9ad5-725673b25fa4; slide submitter id: TCGA-EK-A2H0-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 85.0; percent tumor nuclei: 94.0; section location: TOP;